April 2, 2025

Ucan Ireland: A New Voice for Cancer Patients’ Rights

Community Resource Consultants Inc. (CRCI)

Community Resource Consultants Inc. (CRCI) is a Michigan-based organization specializing in trauma rehabilitation medical case management. With over 34 years of experience, CRCI is dedicated to empowering survivors of catastrophic auto accidents to regain control of their lives and achieve both physical and emotional well-being. Their team of Licensed Master Social Workers (LMSWs) and Registered Nurses (RNs) are experts in navigating the complexities of today’s healthcare system, ensuring that survivors receive the necessary services for their recovery and rehabilitation. CRCI’s core values include advocacy, people, knowledge, and dependability, reflecting their commitment to being leading advocates and facilitators of long-term collaborative care.

News Summary

Ucan Ireland, a new patient advocacy group co-chaired by cancer survivors, aims to improve access to essential cancer medications in Ireland. Highlighting the struggles faced by patients, the group calls for government reforms to expedite drug approvals and ensure timely access to potentially life-saving treatments. The initiative has already garnered attention from government officials, marking a hopeful step towards addressing the critical issues surrounding cancer medication access.

Ucan Ireland Launches to Fight for Cancer Medication Access

In an inspiring move aimed at reshaping the landscape for cancer patients, a brand-new patient advocacy group named Ucan Ireland has stepped in to tackle the critical issue of accessing essential cancer medications. Co-chaired by individuals with personal battles against cancer, this group is on a mission to unify voices from various cancer communities across the country.

The Heart Behind Ucan Ireland

Leading the charge is Miriam Staunton, a passionate advocate who found herself on the front lines of cancer treatment after being diagnosed with stage 3 melanoma back in 2018. Staunton acknowledges that the most pressing issue for cancer patients today is the struggle to secure timely access to the latest drugs. She points out that the situation has not only remained challenging but has, in fact, worsened over time.

A Call for Unity Among Patients

Ucan Ireland isn’t just for one type of cancer; it actively seeks to represent a vast range of cancer types, rallying advocates from different backgrounds and experiences to stand together. By bringing together such a diverse group, they hope to amplify their message and push for meaningful changes in how cancer medications are accessed.

Government Engagement Proves Encouraging

Even before Ucan Ireland officially launched, they caught the attention of the Health Minister, who reached out to express a desire to engage with them. This recognition by government officials is a promising sign that their passionate work may capture the right eyes and ears.

The Reality of Delayed Drug Approvals

Recent reports from the OECD and various industry experts reveal a worrying trend: Ireland lags behind many of its Western European neighbors when it comes to approving new cancer treatments. While Denmark managed to approve a staggering 36 EMA-approved medicines in an average of only 134 days between 2019 and 2022, Ireland managed just 14 approvals taking an average of 600 days. This stark contrast highlights the need for urgent reforms to speed up the approval process.

Shocking Statistics on Cancer Drug Access

According to the OECD, Ireland ranks at a concerning 21st out of 25 in the realm of access to medications that offer high clinical benefits, with less than 40% availability. Adding to the plight, many European nations boast early access schemes that allow patients to start treatments while negotiations on pricing are still in play—a system unfortunately missing from Ireland’s healthcare framework.

Financial Burdens and Personal Stories

The financial implications are equally daunting, with medications accounting for over 13% of the Health Service Executive’s budget, which is already beleaguered by continual overruns. Among the co-chairs, James Hastings shared his harrowing experience of being denied important immunotherapy drugs after his diagnosis of stage 4 cholangiocarcinoma in June 2023. Seeking treatment abroad, he raised €300,000 locally just to get the care he desperately needed. This story exemplifies the urgent need for reform in the medicine reimbursement system, which Ucan Ireland believes is failing patients across the board.

Time is of the Essence for Cancer Patients

With cancer treatment, timing is everything. Ucan Ireland highlighted countless heart-wrenching moments where patients know alternatives are available, yet are unable to access them due to bureaucratic hurdles. Staunton has shared the painful experience of waiting for treatments that could have potentially been available to her in other European countries, discussions which are all too familiar among the members of Ucan Ireland.

Advocacy for Change

Ucan Ireland is dedicated to pushing the government to review drug reimbursement processes, although lingering questions about timelines for these changes still remain. This new advocacy group stands firmly on the belief that accessibility to life-saving medications should not be a privilege but a basic right for everyone battling cancer. In a heartfelt letter submitted to Leinster House, they continue to advocate for faster access to necessary treatments, reflecting their commitment to making a difference.

A Community of Hope and Support

This newly formed group is not just a voice, but a community of advocates who have faced personal challenges across a range of cancer types and stages. They are determined to drive change to ensure that no one else has to experience the frustration and despair that comes with being unable to access life-saving treatments.

Ucan Ireland is built on the foundation of independence, being fully funded by its members rather than pharmaceutical companies, allowing it to advocate freely and effectively for the needs of cancer patients. In a world where access to timely medication is not just a luxury but a necessity, the formation of Ucan Ireland serves as a beacon of hope for many. Together, they are fighting for a future where every cancer patient can access the medications they need when they need them.